Drugs / autologous micro-fragmented adipose tissue
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03117608 | Feb 2017 → Aug 2022 | osteoarthritis, knee | Lipogems International spa | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous micro-fragmented adipose tissue | “injection of autologous micro-fragmented adipose tissue (aMAT)” NCT03117608 ↗ |
| Known as | aMAT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03117608 ↗ |
| Route | Other | “intra-articular injection” NCT03117608 ↗ |